Undermining Value-Based Purchasing - Lessons from the Pharmaceutical Industry

N Engl J Med. 2016 Nov 24;375(21):2013-2015. doi: 10.1056/NEJMp1607378. Epub 2016 Oct 12.

Authors

Leemore S Dafny¹, Christopher J Ody¹, Matthew A Schmitt¹

Affiliation

¹ From Harvard Business School, Boston, and the National Bureau of Economic Research, Cambridge - both in Massachusetts (L.S.D.); the Kellogg School of Management, Northwestern University, Evanston, IL (C.J.O.); and the UCLA Anderson School of Management, Los Angeles (M.A.S.).

PMID: 27732125
DOI: 10.1056/NEJMp1607378

No abstract available

MeSH terms

Cost Sharing*
Drug Costs
Drug Industry / economics*
Medicare / economics*
Prescription Fees*
United States
Value-Based Purchasing*